KCT is a limited company based in Kuopio, Finland that was founded in 2017. We undertake pioneering high-quality basic and translational research in the new and exciting area of Advanced Therapeutic Medicinal Products (ATMPs).
Our scientific teams combine scientific know-how gained from years of experience in the sector and the latest technologies to research and develop cell therapy products into Phase I human studies.
We undertake science in collaboration with academic groups, CROs, CDMOs and regulatory teams to ensure a product path from research to patients. Our main therapeutic focus is cancer but our scope of interest is not fixed and we are also evaluating other disease areas.